Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
National Cancer Institute (NCI)
Novartis
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center